The International Trade Commission said Thursday it will investigate Chinese state support in the biotechnology sector as part of a pair of new probes looking at the U.S. trade relationship with ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...
John Flavin , Portal Innovations CEO, joins 'Fast Money' to discuss if there is still room to run in the biotech space. Got a confidential news tip? We want to hear from you. Sign up for free ...
GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results